The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024 FDA Dihexa Peptide in Austin, TX Saving Face Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. Dihexa 1mL(10 mM in DMSO) Neurotrophic Peptide Enhancer APExBIO